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Abstract
Creatine (Cr), phosphocreatine (PCr), and creatine kinases (CK) comprise an
energy shuttle linking ATP production in mitochondria with cellular con-
sumption sites. Myocytes cannot synthesize Cr: these cells depend on uptake
across the cell membrane by a specialized creatine transporter (CrT) to main-
tain intracellular Cr levels. Hypoxia interferes with energy metabolism, includ-
ing the activity of the creatine energy shuttle, and therefore affects
intracellular ATP and PCr levels. Here, we report that exposing cultured car-
diomyocytes to low oxygen levels rapidly diminishes Cr transport by decreas-
ing Vmax and Km. Pharmacological activation of AMP-activated kinase
(AMPK) abrogated the reduction in Cr transport caused by hypoxia. Cr sup-
plementation increases ATP and PCr content in cardiomyocytes subjected to
hypoxia, while also significantly augmenting the cellular adaptive response to
hypoxia mediated by HIF-1 activation. Our results indicate that: (1) hypoxia
reduces Cr transport in cardiomyocytes in culture, (2) the cytoprotective
effects of Cr supplementation are related to enhanced adaptive physiological
responses to hypoxia mediated by HIF-1, and (3) Cr supplementation
increases the cellular ATP and PCr content in RNCMs exposed to hypoxia.
Introduction
Hypoxia plays a key role in the pathogenesis of coronary
artery disease, stroke, and peripheral artery disease
(Michiels 2004). Exposure to low oxygen content alters
many systems that are needed for energy homeostasis:
oxidative phosphorylation is inhibited, and creatine kinase
activity and intracellular creatine (Cr), phosphocreatine
(PCr), and ATP levels are decreased (Jennings and Reimer
1991). Profound alterations in Cr and PCr levels are con-
sistently observed in heart failure (Neubauer 2007) and in
the peri-infarct region of the heart in animal models of
ischemic injury (Hu et al. 2006). Cardiomyocytes cannot
synthesize Cr and depend on transport across the cell
membrane to maintain intracellular Cr levels. Cr transport
is provided by a membrane protein, the creatine
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
2017 | Vol. 5 | Iss. 16 | e13382
Page 1
Physiological Reports ISSN 2051-817X
transporter (CrT), which belongs to the SLC6 gene family
of transporters (Nash et al. 1994; Snow and Murphy
2001). CrT is a symporter that uses the energy accumu-
lated in the sodium gradient across the membrane to drive
the “uphill” transport of Cr into the cell. During the trans-
port cycle, a Cl ion is also translocated into the cell with
a stoichiometry of 2Na+:1Cl:1Cr (Wyss and Kaddurah-
Daouk 2000). Homeostasis of intracellular Cr content is
therefore controlled by modulation of Cr transport capac-
ity. In cardiac and skeletal myocytes, Cr uptake is affected
by the extracellular Cr concentration: increases in extracel-
lular Cr content decrease Cr uptake (Loike et al. 1988;
Darrabie et al. 2011), whereas decreases in Cr content
increase Cr uptake (Loike et al. 1988; Darrabie et al.
2011). These changes in Cr transport capacity are sec-
ondary to an increase or decrease in Vmax, with no alter-
ation in Km. Recently, we (Darrabie et al. 2011) and others
(Li et al. 2010) have demonstrated that activation of AMP-
activated kinase (AMPK), the cell’s energy master regulator
(Hardie et al. 2012), modulates Cr transport in a tissue-
specific manner. AMPK activation increases Vmax of Cr
transport in cardiomyocytes in culture, whereas AMPK
activation in a kidney cell line decreases Cr transport. In
cardiomyocytes, these changes in Vmax correlate with
changes in abundance of the cell-surface fraction of CrT
protein, indicating that changes in the cell-surface popula-
tion are associated with the cellular responses to extracellu-
lar Cr availability. In the heart, AMPK is activated by
hypoxia, upregulating energy-producing pathways and
decreasing energy expenditure (Kemp et al. 1999; Dyck
and Lopaschuk 2006). AMPK activation also appears to
have a protective effect in animal models of cardiac ische-
mia (Borger et al. 2008; Kim et al. 2011; Li et al. 2013).
Changes in the expression of hypoxia-inducible factor-
1 (HIF-1), a transcription factor required for cellular
adaptation to low-oxygen conditions, are also likely rele-
vant. HIF-1 is composed of a and b subunits; HIF-1b
levels are not altered by normoxia, whereas HIF-1a is
normally ubiquitinated and targeted for proteosomal
degradation. During hypoxia, HIF-1a is no longer tar-
geted for degradation and forms a dimer with HIF-1b,
becoming a transcription factor that interacts with hypox-
ia-responsive elements (HREs), upregulating the expres-
sion of genes such as VEGF, NOS2, adrenomedullin,
endothelin 1, erythropoietin, GLUT1, and GLUT3, among
others (Wenger 2000; Su et al. 2002; Sharp and Ber-
naudin 2004; Ziello et al. 2007). Together, the activation
of AMPK and HIF-1 signaling pathways are thought to
constitute a functional axis critical for the survival of cell
exposed to hypoxia (Wang et al. 2012).
The benefits of Cr supplementation in the presence of
oxidative stress, a hallmark of tissues subjected to hypox-
ia, have been demonstrated in vitro and in animal
models. For example, C2C12 myoblasts supplemented
with Cr and challenged with H2O2 were capable of differ-
entiating into myotubes, whereas nonsupplemented
H2O2-treated C2C12 were not (Sestili et al. 2009). Simi-
larly, protective effects against oxidative stress were
observed in spinal cord neuroblast cell cultures supple-
mented with Cr (Sestili et al. 2009) and in rodent models
of cerebral ischemia (Zhu et al. 2004; Prass et al. 2007;
Perasso et al. 2013), stroke (Prass et al. 2007), Hunting-
ton’s disease (Dedeoglu et al. 2003), and fetal hypoxic
stress (Ireland et al. 2011; Dickinson et al. 2014).
Recently, it was reported that an increase in cardiac Cr
content exerted a protective effect in a rodent model of
ischemia and reperfusion (Lygate et al. 2012). Finally, we
have demonstrated that Cr supplementation ameliorates
oxidative stress caused by doxorubicin in cultured car-
diomyocytes (Santacruz et al. 2015).
In this study, we analyzed the effects of hypoxia on
CrT transport kinetics, which has not been reported pre-
viously. We tested the hypothesis that hypoxia decreases
CrT function. Rat neonatal cardiomyocyte (RNCM) cul-
tures were used in a validated in vitro experimental
design that recapitulates ischemia-induced hypoxia. We
also evaluated the effect of Cr supplementation on HIF-1
activation and cell survival. We report that exposure of
cardiomyocytes in culture to low oxygen rapidly dimin-
ishes Cr transport by decreasing Vmax and Km. Cr supple-
mentation significantly increases ATP and PCr content
and augments HIF-1 activation, thereby increasing the
cellular adaptive response to hypoxia.
Materials and Methods
Cell culture and hypoxia model validation
RNCMs were harvested from 2-day-old Sprague Dawley
pups as described previously (Bursac et al. 1999; San-
tacruz et al. 2015) following protocols approved by the
Institutional Animal Care and Use Committees at Duke
University, Harvard Medical School and Brigham
Women’s Hospital. Hypoxia was achieved by placing the
cells in a hypoxia incubator chamber (STEMCELL Tech-
nologies, Vancouver, BC) filled with a 5% CO2-nitrogen
balanced gas mixture for 5 min at 15 L/min (final oxy-
gen < 1% inside the chamber). The experimental model
was validated by quantifying HIF-1-mediated transcrip-
tional activity measured using the HRE luciferase reporter
gene as described previously (Lima et al. 2009). RNCMs
were transduced with HRE adenovirus (HRE-Ad, 200
viral particles/cell). Forty-eight hours after transduction,
the cells were incubated in hypoxic conditions for varying
times (2–24 h as noted in figure legends). HIF-1 activa-
tion was determined by measuring luciferase expression
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using the luciferase assay system (Promega, Madison WI).
As per experimental design, cultures were supplemented
for 24 h with 1 mmol/L Cr and/or 0.5 mmol/L AICAR
before a 12-h incubation in hypoxic conditions, where
supplementation was continued.
CrT-AAV preparation and transduction of
RNCM cells
RNCMs have low Cr transport; therefore, to facilitate the
kinetic and biochemical analysis of Cr transport in
RNCMs exposed to hypoxia, an adeno-associated virus
encoding the human isoform of CrT was prepared by
excising the CrT open reading frame from a pcDNA 3.1
construct described previously (Darrabie et al. 2012)
using EcoRI and HindIII restriction enzymes and ligated
into the pTR vector. Recombinant CrT-AAV was gener-
ated by standard triple transfection method (Grieger et al.
2006) using XX6-80 helper plasmid with the SASTG
packaging plasmid (Piacentino et al. 2012) and the CrT-
TR plasmid. Recombinant SASTG-CrT was purified and
viral titer was evaluated by dot-blot hybridization (Grie-
ger et al. 2006). Experimentation began 48 h after cells
were transduced with 3000 viral particles/cell.
Immunoblots
RNCMs were cultured in six-well plates. Cells were
scraped in ice-cold lysis buffer (150 mmol/L NaCl, 1%
Triton X-100, 50 mmol/L Tris-HCl, pH 7.4) containing
protease inhibitors (mini-Complete protease inhibitors,
Roche Indianapolis, IN) and phosphatase inhibitors
(5 mmol/L NaF, 1 mmol/L phenylmethylsulfonylfluoride,
2.5 mmol/L Na2P2O7, 50 mmol/L b-Glycerol, 1 mmol/L
Na3VO3, Sigma St Louis, MO). Cell lysates were cen-
trifuged at 4°C for 30 min at 100,000g. The supernatant
protein concentration was determined by bicinchoninic
acid (BCA) protein assay (Pierce Biotechnology). Super-
natants were mixed with sample buffer (125 mmol/L
Tris-HCl, pH 6.8, 20% glycerol, 6% sodium dodecyl
sulfate, 10% b-mercaptoethanol) and then boiled for
3-5 min. Equal amounts of protein were subjected to
SDS-PAGE and transferred to nitrocellulose or PVDF
membranes. For AMPK detection, membranes were
probed with rabbit anti-alpha AMPK antibodies to detect
total AMPK and rabbit anti-AMPK phosphothreonine
(Thr-172) to detect activated AMPK, both at a 1:1000
dilution. Phospho-acetyl-CoA carboxylase (pACC; a
downstream target of AMPK) was detected with 1:100
dilutions of rabbit anti-phospho-ACC. The secondary
antibody was HRP-conjugated goat anti-rabbit at a
1:10,000 dilution. TATA box binding protein was used as
a loading control on immunoblots. It was detected using
a 1:1000 dilution of mouse monoclonal antibody and
purchased from AbCam (Cambridge, MA). All other pri-
mary antibodies were purchased form Cell Signaling
Technology (Danvers, MA). Bands were visualized using an
ECL Western blotting detection system GE Healthcare (Pis-
cataway, NJ) and quantified by densitometry using the
ImageJ algorithm (National Institutes of Health, Bethesda).
Apoptosis and cellular viability assays
Cell viability was measured using the luminescent CellTi-
ter-Glo Viability Assay (Promega, Madisom WI). Apopto-
sis was quantified by measuring the activity of Caspase
3/7 using the Caspase-Glo 3/7 kit (Promega Madison, WI).
14C-Cr transport measurements in RNCMs
14C-Cr uptake was measured in triplicate as described pre-
viously (Darrabie et al. 2011). Cells were washed twice
with choline buffer (150 mmol/L choline chloride;
1 mmol/L CaCl2; 5 mmol/L MgCl2; 2 mmol/L KCl;
5 mmol/L HEPES-Tris, pH 7.5) at room temperature, fol-
lowed by a 10-min incubation at 37°C in a humidified 5%
CO2 incubator in sodium uptake buffer (150 mmol/L
sodium chloride; 1 mmol/L CaCl2; 5 mmol/L MgCl2;
2 mmol/L KCl; 5 mmol/L HEPES-Tris, pH 7.5) radiola-
beled with 0.550 lCi/mL for RNCM 14C-Cr (55 mCi/
mmol; American Radiolabeled Chemicals, St. Louis, MO),
with final Cr concentration for time course experiments
adjusted to 15 lmol/L using a nonradiolabeled compound.
Uptake was terminated by aspirating the radiolabeled solu-
tion, followed by three washes with ice-cold choline buffer.
The cells were lysed in 0.5 mL of 500 mmol/L NaOH and
heated to 80°C for 30 min. A 100 lL aliquot of lysed cells
was subjected to scintillation counting in a Beckman Coul-
ter LS 6500 liquid scintillation counter. Cr transport was
normalized to protein concentration. Cr uptake data were
expressed as nanomoles per milligram of protein. Protein
concentration was determined using the bicinchoninic acid
protein assay (Pierce Biotechnology) and bovine serum
albumin as a standard. For kinetic analysis, cells were
grown in 24-well plates and transduced as described ear-
lier. During the uptake assays, the extracellular Cr concen-
trations ranged from 5 lmol/L to 305 lmol/L as described
earlier. The number of independent experiments used for
data analysis is noted in the corresponding figure legend.
Michaelis–Menten plots were generated using curve-fitting
software (SigmaPlot ver. 9.0).
Quantitation of Cr, PCr, and ATP
Cellular Cr content was quantified using colorimetric
assay (BioVision, Milpitas, CA). RNCMs were cultured in
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24-well plates as described earlier. Cr content was mea-
sured following the manufacturer’s protocols and
expressed relative to protein content. ATP and PCr con-
tent were measured as described by Loo et al. (Wibom
et al. 1991; Loo et al. 2015) in RNCMs grown in 24-well
plates as described earlier. ATP was measured using Lon-
za’s ViaLight plus kit (Salisbury, MD). PCr was deter-
mined using a luminometric assay in perchloric acid
cellular extracts following the addition of creatine kinase
and ADP as described in Wibom et al. (1991). Data
reported are the mean  standard error of the mean
(SEM), of triplicates, obtained from three independent
experiments, and normalized to control values.
Statistical analysis
Data are reported as mean  SEM. Data were analyzed
using T-test, ANOVA, or two-way ANOVA as appropri-
ate. Tukey’s test was used for post hoc, pairwise, inter-
group comparisons (Prism 7) where indicated. Alpha
error values <0.05 were considered significant.
Results
Model validation
To ensure that our experimental design reproduced the
physiological responses to hypoxia, we quantitated the
magnitude and time course of HIF-1 activation using a
luciferase reporter assay. RNCM cultures were transduced
with an adenovirus-encoding luciferase under the control
of the hypoxia response element (AdHRE-luc). The inten-
sity of the luminescent response is proportional to the
amount of active HIF-1 that interacts with the hypoxia
response element (Lima et al. 2009). A statistically signifi-
cant (~140%) increase in HIF-1 activity was measured
after 12 h of incubation in hypoxic conditions (Fig. 1A).
HIF-1 activity continued increasing throughout the 24 h
of incubation in hypoxic conditions, indicating that the
experimental model recapitulates the cellular responses to
low oxygen.
To evaluate the effects of hypoxia on cultured RNCMs,
cell viability was measured by quantifying metabolically
active cells (Fig. 1B). There was a significant decrease
after 1 hour of incubation in low-oxygen conditions.
There was no further decrease in metabolically active cells
if incubation in low oxygen was continued beyond 12 h.
The onset of apoptosis was determined by measuring Cas-
pase 3/7 activation. A statistically significant (~60%)
increase in protease activity indicating increased apoptosis
was detected after 6 h of growth in a hypoxic environ-
ment (Fig. 1C). Incubation after 1 h in low oxygen also
resulted in a loss of spontaneous contractile activity.
Hypoxia reduces Cr transport in RNCM
14C-Cr uptake was measured to determine the effects of
hypoxia on Cr transport. Cr transport decreased signifi-
cantly within the first 3 h of incubation in hypoxic
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Figure 1. Validation of RNCM hypoxia model. (A) RNCMs
transduced with AdV-HRE luciferase were incubated in low-oxygen
conditions (<1% O2). HIF-1 transcriptional activity, quantified by
luciferase activity measure, increased as a function of incubation
time spent in hypoxia. An “*” denotes a statistically significant
difference compared with control. Data represent mean  SEM
(n = 4, ANOVA, P < 0.05, Tukey’s test). (B) Cellular viability was
assessed as described in Materials and Methods. A significant
decrease in viability was detected after 1 hour of incubation in
hypoxia. An “*” denotes a statistically significant difference
compared with control. Data represent mean  SEM (n = 4,
ANOVA, P < 0.05, Tukey’s test). (C) Apoptosis was quantified by
measuring Caspase 3/7 activity. A significant increase in caspase
activity was detected after 6 h of incubation in hypoxia. An “*”
denotes a statistically significant difference compared with control.
Data represent  SEM (n = 3, ANOVA, P < 0.05, Tukey’s test).
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conditions and continued to decline in a time-dependent
manner (Fig. 2A). The decline in Cr transport observed
in RNCMs exposed to hypoxic conditions matched the
observed decrease in viability (Fig. 1B) and antedated sig-
nificant increases apoptosis (Fig. 1C).
RNCMs have low Cr transport capacity, which makes
the determination of kinetic parameters such as Vmax and
Km by
14C-Cr uptake technically difficult. To better char-
acterize the mechanisms mediating the decrease in Cr
transport, we transduced RNCM cultures with an adeno-
associated virus (AAV) encoding the human isoform of
CrT. We utilized a novel engineered AAV termed SASTG
that conferred enhanced cardiac transduction (Piacentino
et al. 2012) to deliver cDNA encoding CrT into
cardiomyocytes. Transduced RNCMs exhibited Cr trans-
port (Fig. 2B) with characteristic saturation kinetics and
Vmax of 90.31  7.07 nmol/mg protein and a Km of
30.76  5.34 lmol/L, which are well within the values
reported in the literature (Loike et al. 1988; Dai et al.
1999; Darrabie et al. 2011). Characterization of kinetics of
Cr transport in transduced RNCMs subjected to hypoxia
for 12 h revealed a significant decrease in Vmax (from
90.31  7.07 to 30.76  5.24 nmol/mg of protein) and
Km (from 30.76  5.24–7.20  1.11 lmol/L) compared
with controls (n = 3, t-test P < 0.05).
Pretreatment with AICAR prevents the
decrease in Cr uptake induced by hypoxia
Previously, we demonstrated that pharmacological activa-
tion of AMPK increases Cr transport in cardiomyocytes
(Darrabie et al. 2011). Therefore, we tested the effect of
pharmacological AMPK activation by 0.5 mmol/L AICAR
beginning 24 h before exposure to hypoxia. Cr transport
was significantly higher than that observed in controls
(cultures exposed to hypoxia that did not receive AICAR)
and remained elevated throughout the time course of the
experiment (Fig. 3).
The activation of AMPK by AICAR and hypoxia was
verified by densitometric quantification of the ratio of
kinase phosphorylated at Thr172 (representing the active
AMPK form, pAMPK) on immunoblots (Fig. 4C). The
results indicate that sustained exposure to hypoxia and
AICAR significantly increased the activation of AMPK by
threefold after 24 h of incubation in low oxygen
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Figure 2. Hypoxia decreases Cr transport in RNCMs. (A) 14C-Cr
uptake was measured in RNCM cultures grown in a hypoxic
atmosphere (<1% O2) for increasing periods of time. The data
present the mean  SEM of four independent 14C-Cr uptake
experiments. An “*” denotes a statistically significant decrease in
transport compared with control cells (ANOVA, P < 0.05, Tukey’s
test). (B) A representative plot of Cr transport measured as a
function of variable Cr concentrations (5–305 lmol/L) is depicted.
Kinetic analysis was performed as described in Materials and
Methods for RNCMs in control conditions (filled circles) or after
12 h of hypoxia (hollow circles). Denoted Vmax and Km values are
mean  SEM. An “*” denotes a statistically significant difference
compared with control normoxia values (n = 3, T-test, P < 0.05).
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Figure 3. AICAR increases Cr transport in RNCMs subjected to
hypoxia. RNCM cultures were pretreated with 0.5 mmol/L AICAR
for 24 h before exposure to hypoxia for increasing periods of time
and before measuring 14C-Cr uptake. Data represent the
mean  SEM of three independent 14C-Cr uptake experiments
normalized to control (measured as nmoles/mg of protein). An “*”
indicates a statistically significant difference in transport compared
with controls (no AICAR and grown in normoxia) and a “+”
indicates a statistically significant difference in transport compared
to AICAR (grown in normoxia) (two-way ANOVA, P < 0.05, Tukey’s
test).
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(Fig. 4A). Although not statistically significant, in the
absence of AICAR, AMPK activation increased by 1.5-fold
after 24 h of incubation in hypoxic conditions. Active
AMPK phosphorylates acetyl-CoA carboxylase (ACC)
and, therefore, the phosphorylated ACC (pACC), can
serve as a biological reporter of AMPK activity (Darrabie
et al. 2011). We measured the effects of incubation in
medium supplemented with AICAR in culture incubated
in low oxygen on the levels of pACC (Fig. 4C). Although
not statistically significant, there appeared to be a pro-
gressive increase in the pACC/ACC ratio with incubation
time in hypoxia, and the increase was accentuated by
incubation with AICAR (Fig. 4B).
Quantitation of ATP, Cr, and PCr
The cellular content of ATP, Cr, and PCr was measured
in RNCM cultures exposed to 12 h of hypoxia in control
media or media supplemented with Cr, AICAR, or both,
and compared to similar cultures grown in the presence
of oxygen (Fig. 5). The results indicate supplementation
with Cr, AICAR, or both increased the mean value of
ATP content; however, this increase did not reach statisti-
cal significance in cultures grown under control oxygen
conditions (Fig. 5A). Hypoxia did not significantly
decrease ATP content in cultures grown in control media.
However, RNCMs that were subjected to hypoxia and
supplemented with Cr had elevated ATP content com-
pared with nonsupplemented cells. Similarly, elevated
ATP content was observed in hypoxia cultures treated
with AICAR and Cr, but not when treated with AICAR
alone. PCr content (Fig. 5B) was significantly elevated in
cultures grown in control oxygen conditions and supple-
mented with Cr or AICAR when compared with nonsup-
plemented conditions. Exposure to hypoxia significantly
decreased PCr content in RNCMs that received AICAR
alone when compared to similar normoxic growth condi-
tions. However, there was no significant decrease in PCr
content in hypoxic cultures supplemented with Cr or Cr
and AICAR combined. Cr content was also quantified in
cultures supplemented with Cr, AICAR, or both following
12 h of hypoxia and compared with RNCMs grown in
similar conditions and control oxygen levels. There were
no statistically significant differences in Cr content among
the different culture conditions (Fig. 5C).
Cr supplementation augments HIF-1
expression
We tested the effects of Cr supplementation (preincuba-
tion) alone or in combination with AICAR on HIF-1 acti-
vation in cardiomyocytes exposed to 12 h of hypoxia
(Fig. 6). Cr supplementation of hypoxic cells significantly
increased HIF-1 activity above that recorded in RNCMs
exposed to hypoxia alone. Preincubation with AICAR had
the opposite effect, significantly decreasing HIF-1 activity.
RNCM cultures that were preincubated with media sup-
plemented with both Cr and AICAR also had significantly
increased HIF-1 activity compared with controls, of a
magnitude similar to that recorded in cultures supple-
mented with Cr only.
Discussion
Hypoxia has deleterious effects on energy metabolism,
ultimately reducing ATP and PCr stores in tissues. In this
study, we evaluated the effect of hypoxia on Cr transport
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Figure 4. Quantification of AMPK activity in response to AICAR
and/or hypoxia. (A) RNCM cultures were pretreated with or without
0.5 mmol/L AICAR for 24 h before exposure to hypoxia for the
indicated time periods. The ratio of pAMPK/AMPK was determined
using densitometry as described in Materials and Methods. Each
bar represents means  SEM of three independent experiments,
normalized to control. An “*” denotes statistically significant
difference compared with control at 0 h, and a “+” denotes
statistically significant difference compared with AICAR at 0 h (two-
way ANOVA, P < 0.05, Tukey’s test). (B) The pACC/ACC ratio was
determined using densitometry as described in Materials and
Methods. Each bar represents the mean  SEM of three
independent experiments (two-way ANOVA, P = ns). (C)
Representative immunoblots of pAMPK and pACC. TATA binding
protein (TBP) was used as a loading control.
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in cardiomyocytes in culture. Cr transport decreased
rapidly in RNCMs incubated in low-oxygen conditions by
as much as 35%. We evaluated the mechanisms responsi-
ble for the decrease in transport capacity by quantifying
the effect of 12 h of incubation in low oxygen on Vmax
and Km of transport. This time point was selected for our
studies due to a significant activation of the hypoxia
adaptive cellular responses, demonstrated by the HRE-
luciferase reporter assay at this time (Fig. 1A). RNCMs
have inherently low Cr transport capacity, thus making
accurate determination of Vmax and Km by
14C-Cr uptake
impossible. To overcome this limitation, we transduced
RNCMs with an adeno-associated virus that expresses the
human CrT protein. Cr transport in transduced cells had
characteristics similar to those reported previously in the
literature for cardiomyocytes in culture (Darrabie et al.
2011). Kinetic analysis demonstrated a significant decrease
in Vmax (by 56%) and Km (by 76%) compared with val-
ues measured in transduced cells grown under normoxic
conditions. The decrease in Vmax, a functional measure-
ment of active cell membrane transporters, indicates that
the cell surface content of CrT protein is decreased, as
previously demonstrated (Darrabie et al. 2011, 2012). A
decrease in Km indicates altered binding or release of Cr
from the transporter, which decreases overall transport
capacity. Taken together, these alterations in kinetic
parameters suggest that hypoxia not only decreases the
number of active transporters on the cell surface, but may
also alter the structure of the CrT protein in such a way
that the interactions with Cr during the substrate
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Figure 5. Quantification of ATP, PCr, and Cr. RNCM cultures were
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was measured as described in Materials and Methods. Each bar
represents the mean  SEM of three independent measurements,
normalized to control values. An “*” denotes a statistically
significant difference compared with controls at the same hypoxia
time point, a “+” denotes a statistically significant difference
compared with Cr at 0 h, a “^” denotes a statistically significant
difference compared with AICAR at 0 h, and a “#” denotes a
statistically significant difference compared with Cr + AICAR at 0 h
(two-way ANOVA, P < 0.05, Tukey’s test). (B) PCr content was
measured as described in Materials and Methods. Each bar
represents the mean  SEM of three independent measurements,
normalized to control. An “*” denotes a statistically significant
difference compared with Control at the same hypoxia time point,
a “+” denotes a statistically significant difference compared with Cr
at 0 h, and a “^” denotes a statistically significant difference
compared with AICAR at 0 h (two-way ANOVA, P < 0.05, Tukey’s
test). (C) Cr content was measured as described in Materials and
Methods. Each bar represents the mean  SEM of three
independent measurements, normalized to control (two-way
ANOVA, P = ns).
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Figure 6. Creatine supplementation enhances HIF-1 activity in
RNCMs subjected to hypoxia. HIF-1 function was quantified using a
luciferase reporter in RNCM cultures supplemented with 0.5 mmol/
L AICAR, 1 mmol/L Cr, or both for 24 h prior to 12 h incubation in
hypoxic conditions, as described in Materials and Methods. Each
bar represents the mean  SEM of four independent experiments,
normalized to control. An “*” denotes a statistically significant
difference compared with control normoxia and a “+” denotes a
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way ANOVA, P < 0.05, Tukey’s test).
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translocation cycle in the membrane are perturbed. A
potential mechanism at play may be the appearance of
intra- or intermolecular disulfide bonds that form under
increased oxidative stress, which occurs in cells exposed
to hypoxia. Indeed, rearrangements in disulfide bonds
have been shown to underlie functional changes in other
membrane transporters exposed to oxidative environ-
ments, such as the cardiac sodium–calcium exchanger
(NCX1) (Santacruz-Toloza et al. 2000).
AMPK is expressed at high levels in cardiac muscle but
has low activity under normal physiological conditions,
becoming more active during hypoxia (Borger et al. 2008;
Omar et al. 2008). Together, HIF-1 and AMPK activation
are believed to be important for cellular survival (Wang
et al. 2012). Previously, we demonstrated that pharmaco-
logical activation of AMPK increases Cr transport capac-
ity in cultured cardiomyocytes (Darrabie et al. 2011).
Here, we extend our observations to the effects of AMPK
activation on Cr transport during hypoxia. Pharmacologi-
cal AMPK activation not only preserved but actually
increased Cr transport in RNCMs exposed to low oxygen
concentrations (Fig. 3). AICAR also extended the time
course of AMPK activation in RNCMs exposed to hypox-
ia. In the absence of pharmacological stimulation, signifi-
cant AMPK activation was detected after 24 h of hypoxia
in RNCMs (Fig. 4A and B). In these cardiomyocytes, the
HIF-1 mediated cellular mechanisms of adaptation to
hypoxia developed before AMPK activity became statisti-
cally significant (Figs. 1A and 4A). HIF-1 mediated
responses were recorded as early as 6 h after the onset
hypoxia, as demonstrated using a luciferase reporter
under the control of HRE transcription control.
The activation pathways for AMPK and HIF-1 are
independent; however, a recent report demonstrates that
in Caenorhabditis elegans, HIF-1 and AMPK regulate each
other reciprocally in response to oxidative stress. In this
organism, HIF-1 is phosphorylated by AMPK, decreasing
its stability (Hwang et al. 2014). Such a mechanism is
consistent with the reduced HIF-1 activity we observed in
cardiomyocytes supplemented with AICAR and incubated
in hypoxic conditions (Fig. 6), where the boost in AMPK
activity produced by AICAR treatment appears to dam-
pen the early HIF-1 response to hypoxia observed in
RNCMs.
As mentioned previously, Cr supplementation has been
reported to have a protective effect in both neurons, myo-
blasts, and cardiomyocytes in culture when subjected to
hypoxic and increased oxidative stressors (Balestrino et al.
1999, 2002; Adcock et al. 2002; Caretti et al. 2010; Sartini
et al. 2012). Given the role of Cr/PCr in maintaining
ATP levels in the cell, we sought to quantify the effects of
Cr supplementation, as well as that of AMPK activation
alone or in combination with Cr supplementation on
ATP, PCr, and Cr content. Cr cellular content did not
change significantly with hypoxia or supplementations
with Cr alone or in combination with AICAR. Cr is lost
at a rate of 2% per 24 h by spontaneous conversion to
creatinine (Wyss and Kaddurah-Daouk 2000). Therefore,
decreased Cr content due to diminished Cr transport
capacity after incubation in hypoxic conditions may not
be detectable in the time frame assayed. Cellular Cr may
also be compartmentalized, and significant alterations in
these intracellular Cr pools cannot be detected using a
whole cell extract assay, or when testing relatively small
cell numbers.. However, our results indicate that Cr sup-
plementation of RNCMs significantly augments PCr levels
under normal and hypoxic conditions.
Cr supplementation significantly increased ATP content
in RNCMs subjected to hypoxia. In RNCMs incubated in
control media and exposed to hypoxia, the decrease in
ATP levels failed to reach significance when compared
with control conditions. This is contrary to observations
in intact hearts subjected to hypoxia, which very quickly
become depleted of ATP and PCr. Adult cardiomyocytes
depend on b-oxidation of fatty acids to generate ATP,
whereas the neonate cardiomyocytes have not developed
b-oxidation capabilities and use glycolysis as the main
ATP generation pathway (Lopaschuk and Jaswal 2010).
RNCMs are thus capable of maintaining constant ATP
levels even when subjected to prolonged hypoxic stress.
RNCMs spontaneously beat in culture; however, within
1 h of exposure to hypoxia, they stop contracting. There-
fore, the overall consumption of ATP decreases as well,
which would result in the ATP levels not changing signifi-
cantly when compared with RNCMs grown in normoxia.
Further examination of the effect of Cr supplementa-
tion on the adaptive responses of RNCMs to hypoxia
indicated that Cr supplementation initiated before
hypoxia also significantly increased HIF-1 activity com-
pared with controls (hypoxia and no supplementation).
Interestingly, when RNCM cultures were simultaneously
supplemented with Cr and AICAR prior to hypoxia, HIF-
1 activity levels were significantly higher than those
observed in control conditions, but similar in magnitude
to those observed in cultures receiving Cr supplementa-
tion only. These observations suggest that Cr supplemen-
tation relieves the “inhibitory” effect that increased
AMPK activity has on HIF-1 function. Further studies to
elucidate the mechanisms and signaling pathways mediat-
ing Cr supplementation-enhanced HIF-1 are warranted.
An enhancement in the adaptive responses may also
explain the protective effect of Cr supplementation
reported in studies using mouse models of cerebral ische-
mia (Zhu et al. 2004) and stroke (Prass et al. 2007). The
timing and duration of Cr supplementation in relation to
the ischemic insult also needs to be carefully analyzed in
2017 | Vol. 5 | Iss. 16 | e13382
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order to fully realize the potential therapeutic value of Cr
supplementation in a clinical setting.
In summary, we report for the first time that Cr trans-
port is diminished within hours when cultured cardiomy-
ocytes are exposed to hypoxia and that Cr
supplementation significantly magnifies the physiological
responses mediating adaptation and cell survival in low
oxygen. This reduction in Cr transport capacity may con-
tribute to the energy disturbances that characterize the
ischemic heart. Cr supplementation increases ATP and
PCr content in cardiomyocytes subjected to hypoxia. In
addition to these increases, the ability to enhance the
physiological response to oxidative stress, may also under-
lie some of the beneficial effects of Cr supplementation
that have been previously reported, and merits further
study.
Acknowledgments
The authors acknowledge R. Liao, Y. Yang, J. Maclung,
and V. Piacentino for insightful discussions and assistance
with experiments, and Q. Toloza for assistance in the
preparation of this manuscript.
Conflict of Interest
None declared.
References
Adcock, K. H., J. Nedelcu, T. Loenneker, E. Martin,
T. Wallimann, and B. P. Wagner. 2002. Neuroprotection of
creatine supplementation in neonatal rats with transient
cerebral hypoxia-ischemia. Dev. Neurosci. 24:382–388.
Balestrino, M., R. Rebaudo, and G. Lunardi. 1999. Exogenous
creatine delays anoxic depolarization and protects from
hypoxic damage: dose-effect relationship. Brain Res.
816:124–130.
Balestrino, M., M. Lensman, M. Parodi, L. Perasso,
R. Rebaudo, R. Melani, et al. 2002. Role of creatine and
phosphocreatine in neuronal protection from anoxic and
ischemic damage. Amino Acids 23:221–229.
Borger, D. R., L. C. Gavrilescu, M. C. Bucur, M. Ivan, and
J. A. Decaprio. 2008. AMP-activated protein kinase is
essential for survival in chronic hypoxia. Biochem. Biophys.
Res. Commun. 370:230–234.
Bursac, N., M. Papadaki, R. J. Cohen, F. J. Schoen, S. R.
Eisenberg, R. Carrier, et al. 1999. Cardiac muscle tissue
engineering: toward an in vitro model for
electrophysiological studies. Am. J. Physiol. 277:H433–H444.
Caretti, A., P. Bianciardi, G. Sala, C. Terruzzi, F. Lucchina,
and M. Samaja. 2010. Supplementation of creatine and
ribose prevents apoptosis in ischemic cardiomyocytes. Cell.
Physiol. Biochem. 26:831–838.
Dai, W., S. Vinnakota, X. Qian, D. Kunze, and H. Sarkar.
1999. Molecular characterization of the human CRT-1
creatine transporter expressed in Xenopus oocytes. Arch.
Biochem. Biophys. 361:75–84.
Darrabie, M. D., A. J. Arciniegas, R. Mishra, D. E. Bowles,
D. O. Jacobs, and L. Santacruz. 2011. AMPK and substrate
availability regulate creatine transport in cultured
cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 300:
E870–E876.
Darrabie, M. D., A. J. Arciniegas, J. G. Mantilla, R. Mishra,
M. Pinilla Vera, L. Santacruz, et al. 2012. Exposing
cardiomyocytes to subclinical concentrations of doxorubicin
rapidly reduces their creatine transport. Am. J. Physiol.
Heart Circ. Physiol. 303:H539–H548.
Dedeoglu, A., J. K. Kubilus, L. Yang, K. L. Ferrante, S. M.
Hersch, M. F. Beal, et al. 2003. Creatine therapy provides
neuroprotection after onset of clinical symptoms in
Huntington’s disease transgenic mice. J. Neurochem.
85:1359–1367.
Dickinson, H., S. Ellery, Z. Ireland, D. LaRosa, R. Snow, and
D. W. Walker. 2014. Creatine supplementation during
pregnancy: summary of experimental studies suggesting a
treatment to improve fetal and neonatal morbidity and
reduce mortality in high-risk human pregnancy. BMC
Pregnancy Childbirth 14:150.
Dyck, J. R., and G. D. Lopaschuk. 2006. AMPK alterations in
cardiac physiology and pathology: enemy or ally? J. Physiol.
574:95–112.
Grieger, J. C., V. W. Choi, and R. J. Samulski. 2006.
Production and characterization of adeno-associated viral
vectors. Nat. Protoc. 1:1412–1428.
Hardie, D. G., F. A. Ross, and S. A. Hawley. 2012. AMPK: a
nutrient and energy sensor that maintains energy
homeostasis. Nat. Rev. Mol. Cell Biol. 13:251–262.
Hu, Q., X. Wang, J. Lee, A. Mansoor, J. Liu, L. Zeng, et al.
2006. Profound bioenergetic abnormalities in peri-infarct
myocardial regions. Am. J. Physiol. Heart Circ. Physiol.
291:H648–H657.
Hwang, A. B., E. A. Ryu, M. Artan, H. W. Chang, M. H.
Kabir, H. J. Nam, et al. 2014. Feedback regulation via
AMPK and HIF-1 mediates ROS-dependent longevity in
Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 111:
E4458–E4467.
Ireland, Z., M. Castillo-Melendez, H. Dickinson, R. Snow,
and D. W. Walker. 2011. A maternal diet supplemented
with creatine from mid-pregnancy protects the newborn
spiny mouse brain from birth hypoxia. Neuroscience
194:372–379.
Jennings, R. B., and K. A. Reimer. 1991. The cell biology of
acute myocardial ischemia. Annu. Rev. Med. 42:225–246.
Kemp, B. E., K. I. Mitchelhill, D. Stapleton, B. J. Michell, Z. P.
Chen, and L. A. Witters. 1999. Dealing with energy demand:
the AMP-activated protein kinase. Trends Biochem. Sci.
24:22–25.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
2017 | Vol. 5 | Iss. 16 | e13382
Page 9
L. Santacruz et al. Hypoxia Reduces Creatine Transport in Cardiomyocytes
Kim, A. S., E. J. Miller, T. M. Wright, J. Li, D. Qi, K. Atsina,
et al. 2011. A small molecule AMPK activator protects the
heart against ischemia-reperfusion injury. J. Mol. Cell.
Cardiol. 51:24–32.
Li, H., R. Thali, C. Smolak, F. Gong, R. Alzamora, T.
Wallimann, et al. 2010. Regulation of the creatine transporter
by AMP-activated protein kinase in kidney epithelial cells.
Am. J. Physiol. Renal Physiol. 299:F167–F177.
Li, J., D. Qi, H. Cheng, X. Hu, E. J. Miller, X. Wu, et al. 2013.
Urocortin 2 autocrine/paracrine and pharmacologic effects
to activate AMP-activated protein kinase in the heart. Proc.
Natl. Acad. Sci. U.S.A. 110:16133–16138.
Lima, B., G. K. Lam, L. Xie, D. L. Diesen, N. Villamizar,
J. Nienaber, et al. 2009. Endogenous S-nitrosothiols protect
against myocardial injury. Proc. Natl. Acad. Sci. U.S.A.
106:6297–6302.
Loike, J. D., D. L. Zalutsky, E. Kaback, A. F. Miranda, and
S. C. Silverstein. 1988. Extracellular creatine regulates
creatine transport in rat and human muscle cells. Proc. Natl.
Acad. Sci. U.S.A. 85:807–811.
Loo, J. M., A. Scherl, A. Nguyen, F. Y. Man, E. Weinberg,
Z. Zeng, et al. 2015. Extracellular metabolic energetics can
promote cancer progression. Cell 160:393–406.
Lopaschuk, G. D., and J. S. Jaswal. 2010. Energy metabolic
phenotype of the cardiomyocyte during development,
differentiation, and postnatal maturation. J. Cardiovasc.
Pharmacol. 56:130–140.
Lygate, C. A., S. Bohl, M. ten Hove, K. M. Faller, P. J.
Ostrowski, S. Zervou, et al. 2012. Moderate elevation of
intracellular creatine by targeting the creatine transporter
protects mice from acute myocardial infarction. Cardiovasc.
Res. 96:466–475.
Michiels, C. 2004. Physiological and pathological responses to
hypoxia. Am. J. Pathol. 164:1875–1882.
Nash, S. R., B. Giros, S. F. Kingsmore, J. M. Rochelle, S. T.
Suter, P. Gregor, et al. 1994. Cloning, pharmacological
characterization, and genomic localization of the human
creatine transporter. Receptors Channels 2:165–174.
Neubauer, S. 2007. The failing heart–an engine out of fuel.
N. Engl. J. Med. 356:1140–1151.
Omar, M. A., H. Fraser, and A. S. Clanachan. 2008. Ischemia-
induced activation of AMPK does not increase glucose
uptake in glycogen-replete isolated working rat hearts.
Am. J. Physiol. Heart Circ. Physiol. 294:H1266–H1273.
Perasso, L., P. Spallarossa, C. Gandolfo, P. Ruggeri, and
M. Balestrino. 2013. Therapeutic use of creatine in brain or
heart ischemia: available data and future perspectives. Med.
Res. Rev. 33:336–363.
Piacentino, V. 3rd, C. A. Milano, M. Bolanos, J. Schroder,
E. Messina, A. S. Cockrell, et al. 2012. X-linked inhibitor of
apoptosis protein-mediated attenuation of apoptosis, using a
novel cardiac-enhanced adeno-associated viral vector. Hum.
Gene Ther. 23:635–646.
Prass, K., G. Royl, U. Lindauer, D. Freyer, D. Megow,
U. Dirnagl, et al. 2007. Improved reperfusion and
neuroprotection by creatine in a mouse model of stroke.
J. Cereb. Blood Flow Metab. 27:452–459.
Santacruz, L., M. D. Darrabie, J. G. Mantilla, R. Mishra, B. J.
Feger, and D. O. Jacobs. 2015. Creatine supplementation
reduces doxorubicin-induced cardiomyocellular injury.
Cardiovasc. Toxicol. 15:180–188.
Santacruz-Toloza, L., M. Ottolia, D. A. Nicoll, and K. D.
Philipson. 2000. Functional analysis of a disulfide bond in
the cardiac Na(+)-Ca(2+) exchanger. J. Biol. Chem.
275:182–188.
Sartini, S., P. Sestili, E. Colombo, C. Martinelli, F. Bartolini,
S. Ciuffoli, et al. 2012. Creatine affects in vitro
electrophysiological maturation of neuroblasts and protects
them from oxidative stress. J. Neurosci. Res. 90:435–446.
Sestili, P., E. Barbieri, C. Martinelli, M. Battistelli, M. Guescini,
L. Vallorani, et al. 2009. Creatine supplementation prevents
the inhibition of myogenic differentiation in oxidatively
injured C2C12 murine myoblasts. Mol. Nutr. Food Res.
53:1187–1204.
Sharp, F. R., and M. Bernaudin. 2004. HIF1 and oxygen
sensing in the brain. Nat. Rev. Neurosci. 5:437–448.
Snow, R. J., and R. M. Murphy. 2001. Creatine and the
creatine transporter: a review. Mol. Cell. Biochem.
224:169–181.
Su, H., J. Arakawa-Hoyt, and Y. W. Kan. 2002. Adeno-
associated viral vector-mediated hypoxia response element-
regulated gene expression in mouse ischemic heart model.
Proc. Natl. Acad. Sci. U.S.A. 99:9480–9485.
Wang, S., P. Song, and M. H. Zou. 2012. AMP-activated
protein kinase, stress responses and cardiovascular diseases.
Clin. Sci. 122:555–573.
Wenger, R. H. 2000. Mammalian oxygen sensing, signalling
and gene regulation. J. Exp. Biol. 203:1253–1263.
Wibom, R., K. Soderlund, A. Lundin, and E. Hultman. 1991.
A luminometric method for the determination of ATP and
phosphocreatine in single human skeletal muscle fibres.
J. Biolumin. Chemilumin. 6:123–129.
Wyss, M., and R. Kaddurah-Daouk. 2000. Creatine and
creatinine metabolism. Physiol. Rev. 80:1107–1213.
Zhu, S., M. Li, B. E. Figueroa, A. Liu, I. G. Stavrovskaya,
P. Pasinelli, et al. 2004. Prophylactic creatine administration
mediates neuroprotection in cerebral ischemia in mice.
J. Neurosci. 24:5909–5912.
Ziello, J. E., I. S. Jovin, and Y. Huang. 2007. Hypoxia-
inducible factor (HIF)-1 regulatory pathway and its
potential for therapeutic intervention in malignancy and
ischemia. Yale J. Biol. Med. 80:51–60.
2017 | Vol. 5 | Iss. 16 | e13382
Page 10
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Hypoxia Reduces Creatine Transport in Cardiomyocytes L. Santacruz et al.
